SEC Filing Summary: Xenomics, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xenomics, Inc. on June 5, 2008, covering events occurring on May 30, 2008. The filing discloses the entry into a material definitive agreement regarding the company's capital structure and financing options.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or total debt. The only specific financial figures disclosed relate to a potential future investment:
- Maximum Investment Amount: $1,500,000
- Purchase Price: $0.55 per share of common stock
- Instrument: Put Option allowing the company to require the Lead Investor to purchase Units
Material Changes
The primary material change is the execution of Amendment No. 6 to the Warrant and Put Option Agreement originally dated November 30, 2006. This amendment extends the deadline for the Company to exercise its Put Option to require the Lead Investor (Executive Chairman Gian Luigi Longinotti-Buitoni) to invest up to $1,500,000. The new expiration date for exercising this option is June 16, 2008.
Outlook, Risks, and Management Commentary
Management has secured an extension to a financing mechanism that provides potential liquidity. If the Company exercises the Put Option on or before June 16, 2008, the Lead Investor is obligated to purchase the specified Units by June 17, 2008. The filing does not contain forward-looking guidance, risk factors, or commentary on unusual items beyond the terms of this specific amendment.
Investor Verification Checklist
- Verify whether Xenomics, Inc. exercises the Put Option by the June 16, 2008 deadline.
- Confirm the actual number of Units purchased by the Lead Investor if the option is exercised.
- Review the full text of Amendment No. 6 (Exhibit 4.1) for any additional covenants or conditions not summarized here.
- Check subsequent filings for the company's actual cash position and liquidity status post-June 2008.